Cannabis Science Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Cannabis Science are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Cannabis Science has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable forward indicators, Cannabis Science is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Fifty Two Week Low | 0.0020 | |
| Fifty Two Week High | 0.1300 |
Cannabis |
Cannabis Science Relative Risk vs. Return Landscape
If you would invest (100.00) in Cannabis Science on January 25, 2024 and sell it today you would earn a total of 100.00 from holding Cannabis Science or generate -100.0% return on investment over 90 days. Cannabis Science is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Cannabis, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cannabis Science Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cannabis Science's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Cannabis Science, and traders can use it to determine the average amount a Cannabis Science's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CBIS |
Based on monthly moving average Cannabis Science is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cannabis Science by adding Cannabis Science to a well-diversified portfolio.
Cannabis Science Fundamentals Growth
Cannabis Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Cannabis Science, and Cannabis Science fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cannabis Pink Sheet performance.
| Return On Equity | -5.1 | |||
| Return On Asset | -384.61 | |||
| Current Valuation | 14.41 M | |||
| Shares Outstanding | 2.55 B | |||
| Price To Earning | (6.16) X | |||
| Revenue | 7.04 K | |||
| EBITDA | (9.58 M) | |||
| Cash And Equivalents | 29.29 K | |||
| Total Debt | 2.73 M | |||
| Cash Flow From Operations | (1.58 M) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 1.08 M | |||
| Retained Earnings | (139.97 M) | |||
| Current Asset | 395 K | |||
| Current Liabilities | 5.43 M |
Things to note about Cannabis Science performance evaluation
Checking the ongoing alerts about Cannabis Science for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Cannabis Science help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cannabis Science is not yet fully synchronised with the market data | |
| Cannabis Science has some characteristics of a very speculative penny stock | |
| Cannabis Science has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 2.73 M in liabilities. Cannabis Science has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Cannabis Science until it has trouble settling it off, either with new capital or with free cash flow. So, Cannabis Science's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Cannabis Science sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Cannabis to invest in growth at high rates of return. When we think about Cannabis Science's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 7.04 K. Net Loss for the year was (8.36 M) with profit before overhead, payroll, taxes, and interest of 5.21 K. | |
| Cannabis Science currently holds about 29.29 K in cash with (1.58 M) of positive cash flow from operations. |
- Analyzing Cannabis Science's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cannabis Science's stock is overvalued or undervalued compared to its peers.
- Examining Cannabis Science's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cannabis Science's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cannabis Science's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cannabis Science's pink sheet. These opinions can provide insight into Cannabis Science's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Cannabis Pink Sheet
If you are still planning to invest in Cannabis Science check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cannabis Science's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |